Hospital or health organisation · founded 1913
City of Hope
Lancaster, United States · cityofhope.org/location/antelope-valley
- Citations, last 5 years
- 83.9k
- Works, last 5 years
- 7 099
- h-index
- 595
- Scientists listed
- 36
- Grants since 2016
- 654
Grants received
2021–2026 · research · R01
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Lihua Elizabeth Budde · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Lihua Elizabeth Budde · City of Hope · funded by National Institutes of Health
2021–2025 · fellowship · F31
Impact of RNA splicing factor mutations on circular RNA biogenesis in leukemia
Mike Fernandez · City of Hope · funded by National Institutes of Health
2021–2025 · research · R01
The Role of Adipocyte Uridine Biosynthesis in Obesity and Diabetes Progression
Yingfeng Deng · City of Hope · funded by National Institutes of Health
2021 · research · PCF Young Investigator Award
Impact of the Microbiome on PSCA-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy for Prostate Cancer
John P. Murad · City of Hope · funded by Prostate Cancer Foundation
2021–2026 · research · R50
Improving Outcomes for Multiple Myeloma Patients through Novel Therapeutic Interventions
Enrico Caserta · City of Hope · funded by National Institutes of Health
2021–2027 · research · R01
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
Jeremy Michael Stark · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
Vu Nguyen Ngo · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Validation of epigenomic biomarkers for thyroid cancer diagnostics
Maria Hahn · City of Hope · funded by National Institutes of Health
2021–2027 · research · R01
Identifying and engaging a universal adjuvant for breaking macrophage immune tolerance in cancer
Mingye Feng · City of Hope · funded by National Institutes of Health
2021–2027 · research · R01
Develop age-relevant glial cellular models using human directly reprogrammed cells
Yanhong Shi · City of Hope · funded by National Institutes of Health
2021–2027 · cooperative agreement · U01
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
Andrea Hope Bild · City of Hope · funded by National Institutes of Health
2021–2026 · research · R01
Overcoming ibrutinib resistance in mantle cell lymphoma
Alexey V. Danilov · City of Hope · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
Administrative Core
Jana Portnow · City of Hope · funded by National Institutes of Health
2021–2027 · cooperative agreement · U19
Analytical Immunopharmacology
Timothy W Synold · City of Hope · funded by National Institutes of Health
2021–2026 · cooperative agreement · U19
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
Michael E. Berens · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Fatty acids and their receptors-mediated tumor metastasis and progression
David K. Ann · City of Hope · funded by National Institutes of Health
2020–2024 · research · R01
Scalable Bayesian Network analysis of multimodal FACS and SUMOylation data, with generalization to other big mixed biological datasets
Andrei Rodin · City of Hope · funded by National Institutes of Health
2020–2023 · fellowship · F32
Using Cultured Human Mammary Epithelial Cells to Explore the Role of the Yap Oncogene in Early Breast Cancer Progression
Tara Micole Fresques · City of Hope · funded by National Institutes of Health
2020–2025 · research · R25
Interdisciplinary Communication Training in Oncology
Betty R Ferrell · City of Hope · funded by National Institutes of Health
2020–2025 · career development · K08
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes
June-Wha Rhee · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance
Ling Li · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation
Saro Armenian · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
Behnam Badie · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia
Lili Wang · City of Hope · funded by National Institutes of Health
2020–2025 · career development · K08
Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer Care
Ana Isabel Tergas · City of Hope · funded by National Institutes of Health
2020–2026 · research · R01
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
Behnam Badie · City of Hope · funded by National Institutes of Health
2020–2023 · research · R01
The function and underlying mechanism of TET1 in myelodysplastic syndromes
Jianjun Chen · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers
Saro Armenian · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Defining the Role of Adipogenesis in Age-Associated Adiposity
Qiong Annabel Wang · City of Hope · funded by National Institutes of Health
2020–2023 · research · R21
Epigenetic changes and methylglyoxal adducts induced by metabolic regulation in patients with type 1 diabetes that develop complications
Sarah C. Shuck · City of Hope · funded by National Institutes of Health
2020–2023 · research · R00
Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia
Zhaohui Gu · City of Hope · funded by National Institutes of Health
2020–2025 · career development · K08
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes
June-Wha Rhee · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Bile acids and metabolic surgery
Wendong Huang · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
The role of miR-142 in regulatory T cell Development and function
Mark P Boldin · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
The role of miR-142 in regulatory T cell Development and function
Mark P Boldin · City of Hope · funded by National Institutes of Health
2020–2026 · research · R01
Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target?
Guido Marcucci · City of Hope · funded by National Institutes of Health
2020–2021 · contract · N01
PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL-TASK AREA 2, PCT0050-01: HESC-DERIVED CARDIOMYOCYTE PROGENITOR CE
Joseph Gold · City of Hope · funded by National Institutes of Health
2020–2025 · research · R01
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
Behnam Badie · City of Hope · funded by National Institutes of Health
2020–2023 · research · R01
Scalable Bayesian Network analysis of multimodal FACS and SUMOylation data, with generalization to other big mixed biological datasets
Andrei Rodin · City of Hope · funded by National Institutes of Health